Treatment for chronic myeloid leukemia (CML) has evolved from chemotherapy (busulfan, hydroxyurea) to interferon-α (IFNα), and finally to tyrosine kinase inhibitors such as imatinib. Although imatinib ...
Chronic myeloid leukemia (CML) is a hematologic malignancy characterized by the fusion gene BCR-ABL1 and where continuous treatment with tyrosine kinase inhibitors (TKI) has greatly improved the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results